论文部分内容阅读
目的:对采用雾化吸入盐酸氨溴索的方法对患有慢性支气管炎的患者进行辅助治疗的临床治疗效果进行分析,为今后临床对慢性支气管炎患者进行更为有效的治疗提供可靠依据和参考。方法:随机抽取2008年9月-2010年9月于我院就诊的患有慢性支气管炎的确诊患者168例,将其随机分为A、B两组各84例。A组患者在常规治疗方法的基础上采用雾化吸入盐酸氨溴索的方法进行治疗;B组患者在常规治疗的基础上采用雾化吸入糜蛋白酶、庆大霉素和地塞米松的方法进行治疗。对两组患者用药后的并发症、不良反应情况及其治疗效果进行比较分析。结果:采用雾化吸入盐酸氨溴索的方法对患有慢性支气管炎的患者进行辅助治疗,其疗效明显优于采用雾化吸入其他药的方法进行辅助治疗者,有显著统计学差异(P<0.05)。两组患者在用药后没有出现任何并发症和不良反应现象。结论:采用雾化吸入盐酸氨溴索的方法对患有慢性支气管炎的患者进行辅助治疗的临床效果好,毒副作用小,且未出现用药后的并发症和不良反应,值得临床推广应用。
OBJECTIVE: To analyze the clinical effect of adjuvant therapy on patients with chronic bronchitis using inhalation of ambroxol hydrochloride by nebulization, so as to provide a reliable basis and reference for clinical treatment of patients with chronic bronchitis . Methods: A total of 168 patients with chronic bronchitis diagnosed in our hospital from September 2008 to September 2010 were randomly selected and randomly divided into two groups (A and B), 84 cases each. Group A patients were treated with atomization inhalation of ambroxol hydrochloride on the basis of conventional treatment methods. Patients in group B were treated by inhalation of chymotrypsin, gentamicin and dexamethasone on the basis of routine treatment treatment. Comparisons were made between the two groups of patients after treatment of complications, adverse reactions and the treatment effect. Results: The treatment of patients with chronic bronchitis by inhalation of ambroxol hydrochloride by nebulization was significantly better than that by nebulization of other drugs (P < 0.05). Two groups of patients in the medication did not appear any complications and adverse reactions. Conclusion: Ambroxol hydrochloride inhalation by inhalation of patients with chronic bronchitis patients with adjuvant therapy has good clinical effects, small side effects, and did not appear after treatment of complications and adverse reactions, it is worth promoting the clinical application.